September 11, 2013

Pharma is facing ever increasing transparency regulations in Europe. The risk of severe fines and a tarnished reputation means pharma companies need to make sure they are managing risk and adopting ethical business practices. This conference will unite global leaders working in compliance providing fresh insights and best practices for ethical business conduct and risk management. – See more at: